India is set to experience a dramatic shift as Ozempic and Wegovy's active ingredient, semaglutide, becomes widely available. Over 40 Indian companies are launching affordable generic versions, slashing prices and expanding access. This transition promises to…
India is about to get a lot thinner, and a lot more complicated. The expiry of Novo Nordisks patent on semaglutide, the molecule powering blockbuster drugs like Ozempic and Wegovy, is set to unleash … [+7602 chars]
